Machine Learning Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy for ER+HER2- Breast Cancer: Integrating Tumoral and Peritumoral MRI Radiomic Features
Open Access
- 23 September 2023
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 13 (19) , 3031
Abstract
Background: This study aimed to predict pathologic complete response (pCR) in neoadjuvant chemotherapy for ER+HER2- locally advanced breast cancer (LABC), a subtype with limited treatment response. Methods: We included 265 ER+HER2- LABC patients (2010–2020) with pre-treatment MRI, neoadjuvant chemotherapy, and confirmed pathology. Using data from January 2016, we divided them into training and validation cohorts. Volumes of interest (VOI) for the tumoral and peritumoral regions were segmented on preoperative MRI from three sequences: T1-weighted early and delayed contrast-enhanced sequences and T2-weighted fat-suppressed sequence (T2FS). We constructed seven machine learning models using tumoral, peritumoral, and combined texture features within and across the sequences, and evaluated their pCR prediction performance using AUC values. Results: The best single sequence model was SVM using a 1 mm tumor-to-peritumor VOI in the early contrast-enhanced phase (AUC = 0.9447). Among the combinations, the top-performing model was K-Nearest Neighbor, using 1 mm tumor-to-peritumor VOI in the early contrast-enhanced phase and 3 mm peritumoral VOI in T2FS (AUC = 0.9631). Conclusions: We suggest that a combined machine learning model that integrates tumoral and peritumoral radiomic features across different MRI sequences can provide a more accurate pretreatment pCR prediction for neoadjuvant chemotherapy in ER+HER2- LABC.Keywords
Funding Information
- Korea Medical Device Development Fund (KMDF202011A01-04, NRF-2021R1A2C3006264)
- National Research Foundation of Korea (KMDF202011A01-04, NRF-2021R1A2C3006264)
This publication has 34 references indexed in Scilit:
- Evaluation with 3.0-T MR imaging: predicting the pathological response of triple-negative breast cancer treated with anthracycline and taxane neoadjuvant chemotherapyActa Radiologica, 2015
- Metrics for evaluating 3D medical image segmentation: analysis, selection, and toolBMC Medical Imaging, 2015
- Changes in Primary Breast Cancer Heterogeneity May Augment Midtreatment MR Imaging Assessment of Response to Neoadjuvant ChemotherapyRadiology, 2014
- Analysis of Factors that Influence the Accuracy of Magnetic Resonance Imaging for Predicting Response after Neoadjuvant Chemotherapy in Locally Advanced Breast CancerAnnals of Surgical Oncology, 2013
- Comparison of diffusion-weighted with T2-weighted imaging for detection of edema in acute myocardial infarctionJournal of Cardiovascular Magnetic Resonance, 2013
- N4ITK: Improved N3 Bias CorrectionIEEE Transactions on Medical Imaging, 2010
- Doxorubicin With Cyclophosphamide Followed by Docetaxel Every 21 Days Compared With Doxorubicin and Docetaxel Every 14 Days As Preoperative Treatment in Operable Breast Cancer: The GEPARDUO Study of the German Breast GroupJournal of Clinical Oncology, 2005
- Influence of MRI acquisition protocols and image intensity normalization methods on texture classificationMagnetic Resonance Imaging, 2004
- Magnetic resonance with marked T2-weighted images: improved demonstration of brain lesions, tumor, and edemaAmerican Journal of Roentgenology, 1985
- The meaning and use of the area under a receiver operating characteristic (ROC) curve.Radiology, 1982